Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative docetaxel chemotherapy plus radical prostatectomy for untreated metastatic prostate cancer
jRCT1031180387Completed
- Start
- Jul 2019
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of docetaxel in prostate cancer (PCa). Primary endpoint: Progression-free survival. Started Jul 2019; status: completed.
02
Drugs
docetaxel
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on jRCT1031180387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031180387.